A rapid, real-time quantitative polymerase chain reaction test for the identification of pathogens in bronchoalveolar lavage samples

Journal of Trauma and Acute Care Surgery

Volumn 76, Issue 3, 2014, Pages 651-660

  Orlando, Alessandro ^a,b   Thoma, Gregory ^a,b   Slone, Denetta S ^c   Mains, Charles W ^a,d   Bar Or, David ^a,b,d  

^a ST ANTHONY HOSPITAL   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

^c Swedish Medical Center   (United States)

^d Rocky Vista University   (United States)

Author keywords

Bronchoalveolar lavage; Diagnosis; Mechanical ventilation; PCR; Quantitative culture

Indexed keywords

GENOMIC DNA; METICILLIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA ISOLATION; FEMALE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HUMAN; INTERMETHOD COMPARISON; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; DNA, BACTERIAL; DNA, FUNGAL; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84896738996     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000157     Document Type: Article

References (37)

1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867-903.
2. Mariya Joseph N, Sistla S, Kumar Dutta T, Shankar Badhe A, Rasitha D, Chandra Parija S. Outcome of ventilator-associated pneumonia: impact of antibiotic therapy and other factors. Australas Med J. 2012;5(2):135-140.
3. Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, Similowski T, Mercat A, Diehl JL, Sollet JP, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med. 2000;132(8):621-630.
4. Stratidis J, Bia FJ, Edberg SC. Use of real-time polymerase chain reaction for identification of methicillin-resistant Staphylococcus aureus directly from positive blood culture bottles. Diagn Microbiol Infect Dis. 2007; 58(2):199-202.
5. Sandiumenge A, Diaz E, Rodriguez A, Vidaur L, Canadell L, Olona M, Rue M, Rello J. Impact of diversity of antibiotic use on the development of antimicrobial resistance. J Antimicrob Chemother. 2006;57(6):1197-1204.
6. Piskin N, Aydemir H, Oztoprak N, Akduman D, Comert F, Kokturk F, Celebi G. Inadequate treatment of ventilator-associated and hospitalacquired pneumonia: risk factors and impact on outcomes. BMC Infect Dis. 2012;12:268.
7. Hayette MP, Vaira D, Susin F, Boland P, Christiaens G, Melin P, De Mol P. Detection of Aspergillus species DNA by PCR in bronchoalveolar lavage fluid. J Clin Microbiol. 2001;39(6):2338-2340.
8. Khanna M, Fan J, Pehler-Harrington K, Waters C, Douglass P, Stallock J, Kehl S, Henrickson KJ. The pneumoplex assays, a multiplex PCR-enzyme hybridization assay that allows simultaneous detection of five organisms, Mycoplasma pneumoniae, Chlamydia (Chlamydophila) pneumoniae, Legionella pneumophila, Legionella micdadei, and Bordetella pertussis, and its real-time counterpart. J Clin Microbiol. 2005;43(2):565-571.
9. Tueller C, Chhajed PN, Buitrago-Tellez C, Frei R, Frey M, Tamm M. Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis. Eur Respir J. 2005;26(5):767-772.
10. Oh AC, Lee JK, Lee HN, Hong YJ, Chang YH, Hong SI, Kim DH. Clinical utility of the Xpert MRSA assay for early detection of methicillin-resistant Staphylococcus aureus. Mol Med Rep. 2013;7(1):11-15.
11. Abdeldaim GM, Stralin K, Korsgaard J, Blomberg J, Welinder-Olsson C, Herrmann B. Multiplex quantitative PCR for detection of lower respiratory tract infection and meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis. BMC Microbiol. 2010;10:310.
12. Khot PD, Ko DL, Hackman RC, Fredricks DN. Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect Dis. 2008;8:73.
13. Choppa PC, Vojdani A, Tagle C, Andrin R, Magtoto L. Multiplex PCR for the detection of Mycoplasma fermentans, M. hominis and M. penetrans in cell cultures and blood samples of patients with chronic fatigue syndrome. Mol Cell Probes. 1998;12(5):301-308.
14. Volkmann H, Schwartz T, Bischoff P, Kirchen S, Obst U. Detection of clinically relevant antibiotic-resistance genes in municipal wastewater using real-time PCR (TaqMan). J Microbiol Methods. 2004;56(2):277-286.
15. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115(2):462-474.
16. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med. 1996;22(5):387-394.
17. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilatorassociated pneumonia. Chest. 2002;122(1):262-268.
18. Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC. Impact of BAL data on the therapy and outcome of ventilatorassociated pneumonia. Chest. 1997;111(3):676-685.
19. Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156(1):196-200.
20. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest. 1998;113(2):412-420.
21. Raman K, Nailor MD, Nicolau DP, Aslanzadeh J, Nadeau M, Kuti JL. Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy cultures. Critical Care Med. 2013;41(7):1656-1663.
22. Raad I, Hanna H, Huaringa A, Sumoza D, Hachem R, Albitar M. Diagnosis of invasive pulmonary aspergillosis using polymerase chain reactionbased detection of Aspergillus in BAL. Chest. 2002;121(4):1171-1176.
23. Stralin K, Korsgaard J, Olcen P. Evaluation of a multiplex PCR for bacterial pathogens applied to bronchoalveolar lavage. Eur Respir J. 2006;28(3): 568-575.
24. Wang B, Jessamine P, Desjardins M, Toye B, Ramotar K. Direct mecA polymerase chain reaction testing of blood culture bottles growing grampositive cocci and the clinical potential in optimizing antibiotic therapy for staphylococcal bacteremia. Diagn Microbiol Infect Dis. 2013;75(1):37-41.
25. Dubois V, Arpin C, Melon M, Melon B, Andre C, Frigo C, Quentin C. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance. J Clin Microbiol. 2001;39(6):2072-2078.
26. Landman D, Quale JM, Mayorga D, Adedeji A, Vangala K, Ravishankar J, Flores C, Brooks S. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med. 2002;162(13):1515-1520.
27. Van Eldere J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother. 2003;51(2):347-352.
28. Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis. 2001; 32(Suppl 2):S104-S113.
29. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med. 1999;159(4 Pt 1):1249-1256.
30. Guidelines for the management of adults with hospital-acquired, ventilatorassociated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416.
31. Dalhoff K, Braun J, Hollandt H, Lipp R, Wiessmann KJ, Marre R. Diagnostic value of bronchoalveolar lavage in patients with opportunistic and nonopportunistic bacterial pneumonia. Infection. 1993;21(5):291-296.
32. Wheeler J, Freeman R, Steward M, Henderson K, Lee MJ, Piggott NH, Eltringham GJ, Galloway A. Detection of pneumolysin in sputum. J Med Microbiol. 1999;48(9):863-866.
33. Gallego M, Rello J. Diagnostic testing for ventilator-associated pneumonia. Clin Chest Med. 1999;20(3):671-679, x.
34. Meduri GU, Johanson WG Jr. International Consensus Conference: clinical investigation of ventilator-associated pneumonia. Introduction. Chest. 1992;102(5 Suppl 1):551S-552S.
35. Michaud S, Suzuki S, Harbarth S. Effect of design-related bias in studies of diagnostic tests for ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;166(10):1320-1325.
36. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Kehagia V, Jones GR, Bruce KD. Bacterial activity in cystic fibrosis lung infections. Respir Res. 2005;6:49.
37. Rogers GB, Stressmann FA, Koller G, Daniels T, Carroll MP, Bruce KD. Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections. Diagn Microbiol Infect Dis. 2008;62(2):133-141.